产品名称：
(4-甲氧基苄基)(1-萘基甲基)胺盐酸盐(4-甲氧基苄基)(1-萘基甲基)胺盐酸盐生物活性：
| ML133 HCl is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 μM (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1. |
(4-甲氧基苄基)(1-萘基甲基)胺盐酸盐制备储备液：| 浓度溶解体积质量 | 1mg | 5mg | 10mg |
| 1mM | 2.1032mL | 10.5159mL | 21.0318mL |
| 5mM | 0.4206mL | 2.1032mL | 4.2064mL |
| 10mM | 0.2103mL | 1.0516mL | 2.1032mL |
| 50mM | 0.0421mL | 0.2103mL | 0.4206mL |
(4-甲氧基苄基)(1-萘基甲基)胺盐酸盐临床数据( 数据源于：http:// clinicaltrials.gov）
Conversion of different model animals based on BSA（Value based on data from FDA Draft Guidelines）
Animal A (mg/kg)=Animal B（mg/kg）multiplied by
AnimalBm系数/AnimalAm系数 For example, to modify the dose of resveratrol uesd for a mouse(22.4mg/kg) to a dose based on the BSA for a rat, multiply 22.4mg/kg by the Km factor for a mouse and zhen divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2mg/kg
南京赛泓瑞生物科技有限公司是专业从事生化试剂、分子生物学试剂、实验耗材及实验仪器研发、销售、服务为一体的专业性生物科技公司。本着服务科学的理念，赛泓瑞建立了生命科学研究工具的研发、生产、销售及技术服务平台，现已有数万余种产品，并每年不断开发新产品，为广大的生命科学研究人员、医学、药学、农业、环保等的科研人员提供科研工具性产品及技术服务.
经营范围：抑制剂、ELISA试剂盒、原代细胞和细胞株、化学试剂、蛋白、抗体、分子试剂和试剂盒。
